Clinical Trials Browser

Phase 1 × Neoplasms × talazoparib × Clear all

NCT03343054 2024-08-22

A Phase 1 Study Of Talazoparib, PARP Inhibitor, In Japanese Patients With Advanced Solid Tumors

Phase 1 Completed

28 enrolled 43 charts

Breast Neoplasms, Neoplasms

NCT04635631 2023-10-10

STUDY OF TALAZOPARIB MONOTHERAPY IN CHINESE PARTICIPANTS WITH ADVANCED SOLID TUMORS

Phase 1 Completed

15 enrolled 38 charts

Neoplasms